Key result
Therapeutic approaches targeting adipose tissue have proven effective in improving obesity-related metabolic disorders, with promising new therapies in development.
This review highlights the distinct roles of white and brown adipose tissue in energy homeostasis and their implications for metabolic disorders like obesity and lipodystrophy.
White adipose tissue centrally regulates energy homeostasis; leaves open its therapeutic modulation in metabolic disease.
The two types of adipose tissue in humans, white and brown, have distinct developmental origins and functions. Human white adipose tissue plays a pivotal role in maintaining whole-body energy homeostasis by storing triglycerides when energy is in surplus, releasing free fatty acids as a fuel during energy shortage, and secreting adipokines that are important for regulating lipid and glucose metabolism. The size of white adipose mass needs to be kept at a proper set point. Dramatic expansion of white fat mass causes obesity--now become a global epidemic disease--and increases the risk for the development of many life-threatening diseases. The absence of white adipose tissue or abnormal white adipose tissue redistribution leads to lipodystrophy, a condition often associated with metabolic disorders. Brown adipose tissue is a thermogenic organ whose mass is inversely correlated with body mass index and age. Therapeutic approaches targeting adipose tissue have been proven to be effective in improving obesity-related metabolic disorders, and promising new therapies could be developed in the near future.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2013) conducted a review in Obesity and metabolic disorders. Therapeutic approaches targeting adipose tissue have proven effective in improving obesity-related metabolic disorders, with promising new therapies in development.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: